Synapse - Sergio Giralt

Results (297)

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - A single institution pilot study

Research Letter

Lin, R. J.; Dahi, P. B.; Shahrokni, A.; Sarraf, S.; Korc-Grodzicki, B.; Devlin, S. M.; Maloy, M. A.; Shah, G. L.; Jakubowski, A. A.; Giralt, S. A.
Leukemia and Lymphoma (2019)

Fulltext@MSK | Save

Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)

Meeting Abstract

Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma

Meeting Abstract

Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma

Meeting Abstract

Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma

Journal Article

Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
Leukemia (2019)

Fulltext@MSK | Save

Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry

Journal Article

Schofield, R. C.; Landau, H. J.; Giralt, S. A.; Shah, G. L.; Scordo, M.; Lin, A.; Zanutto, E.; Ramanathan, L. V.; Pessin, M. S.; Carlow, D. C.
Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences (2019)

Fulltext@MSK | Save

Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation